Role of anti-vimentin antibodies in allograft rejection. - Wikidata - wikimedia - TriplyDB

Role of anti-vimentin antibodies in allograft rejection.

Role of anti-vimentin antibodies in allograft rejection.

http://www.wikidata.org/entity/Q37286553

about

Vascular endothelium as a target of immune response in renal transplant rejection Haptoglobin enhances cardiac transplant rejection Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss.Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population.What is damaging the kidney in lupus nephritis?Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications.Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells Graft microvascular disease in solid organ transplantation.Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis The importance of non-HLA antibodies in transplantation.The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation.Role of alloimmunity and autoimmunity in allograft rejection.Editorial: autoimmunity to vimentin and lupus nephritis.The relationship between the expression of TN and the efficiency of posterior spinal V osteotomy in patients with traumatic kyphosis.The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection.

P2860

Q27024077-A1472F98-ADFC-4D65-A136-C77C4AA4C471 Q27339208-4A4F15D5-5B0D-4620-8A06-242168B34C6B Q33998148-F1D8F4F3-E6D1-49B0-81C1-4168A5946203 Q35883267-CB7487C8-3928-4C36-9B09-2D0DEEDE9F41 Q36765221-0A9FCDEF-5D6A-4363-9D79-A4FB7C7BEA58 Q37101630-502872E0-1A27-4B99-8DFE-286517FC2D40 Q37642331-D1BE5882-2394-4965-A2D4-92B91AA2FCD5 Q37687763-99D62EF2-9197-4346-A35B-7A6575E4946F Q38216381-975352FF-53D8-4C24-9E57-1A375EE70FF5 Q38654419-8D37AA76-87B3-422F-B2EC-A90780A13B25 Q38877375-3F118142-8908-4A1F-A5B5-019FDBB7E11A Q38995184-9923A7C8-2673-4AE7-BF2E-90732D68C221 Q39268286-92F22B3B-E8BD-45A4-A962-FC02E1FA439A Q41226453-C00885E1-043B-449E-823C-A58200499FF4 Q41833307-B2653B5F-896D-487D-B4E1-9D1E8235C4C7 Q49557996-39DC8947-3AB7-45A2-9BA3-1AD0F26726F0 Q53241382-69638124-2329-417A-8844-ADB051F88E6F

P2860

Role of anti-vimentin antibodies in allograft rejection.

http://www.wikidata.org/entity/Q37286553

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of anti-vimentin antibodies in allograft rejection.

@en

Role of anti-vimentin antibodies in allograft rejection.

@nl

type

label

Role of anti-vimentin antibodies in allograft rejection.

@en

Role of anti-vimentin antibodies in allograft rejection.

@nl

prefLabel

Role of anti-vimentin antibodies in allograft rejection.

@en

Role of anti-vimentin antibodies in allograft rejection.

@nl

P1433

Q37286553-61355E69-BF7D-42F9-8066-12BEBD803334

P1476

Q37286553-162B323C-BFFE-4FB3-9C20-2B2CB3378B6F

P2093

Q37286553-BE57C0F3-F9D0-46C2-BDF0-46C2529583C9

P275

Q37286553-2A82D73E-757A-4FF5-AC53-DEAB8D9735EC

P2860

Q37286553-08389748-9DF6-4FF3-A751-2729616E09D7

Q37286553-107E74CD-0E47-4459-9B1C-DAD45D637FC9

Q37286553-11A93CA1-9F6E-44FD-9D86-19AFB7AA9144

Q37286553-14CFFE3E-3FD4-4414-A947-149CB34C195D

Q37286553-1930DBDF-96BB-4B8A-B938-DE921EC9C261

Q37286553-1D79BB3C-E235-4C59-BC62-153E28E0F877

Q37286553-1D9ECF7E-47A5-4EF3-8990-E480B8AADC01

Q37286553-21E1E0BD-87F7-4750-81D6-6C5EFC0CB31D

Q37286553-33729E56-EE8A-4F91-A3B6-292778725C71

Q37286553-3A2FAFD8-8C50-4F98-9DF2-5998C3B58A4C

P304

Q37286553-05AC8005-34A1-4843-95DF-8C16581C645F

P31

Q37286553-437B4528-BAAF-4EAF-A5E7-2CD533ACCB0E

Q37286553-DBA4081D-B256-483B-ABB1-84C5A60B982B

P356

Q37286553-E2EA8613-756D-41C1-BC3C-5F4899EB5F40

P433

Q37286553-6ECE150B-CCBA-4CFD-A571-534AB58006E3

P478

Q37286553-E1055FFF-D1AF-41F5-A475-104BA0870B42

P577

Q37286553-297CC1D7-CF2E-4478-8989-28DC993C8536

Q37286553-C8E43A13-C5A4-4B82-B297-3D08672F7C76

P5875

Q37286553-07C35D03-3AC2-484F-B00C-70E28B3E4582

P698

Q37286553-EDE8787C-4A27-45A7-99E9-2F61C3560CB9

P921

Q37286553-4C4FBC11-7942-4532-8A88-92CAD2165062

Q37286553-A312B428-0776-48C2-9A2D-31083C4D8882

Q37286553-C755BDCD-6329-474D-BFED-7FFB7DDF24D8

Q37286553-D7D343A8-8CBF-4911-BA05-236B504D8F0E

Q37286553-EDD23571-4C41-45D0-82FB-70EFA127BCA9

P932

Q37286553-8A4CBFA3-601F-4567-A0C2-9DAC680636C2

P356

J.HUMIMM.2013.06.006

P1433

Human Immunology

P1476

Role of anti-vimentin antibodies in allograft rejection.

@en

P2093

Marlene L Rose

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin

The prototype endothelial marker PAL-E is a leukocyte trafficking molecule

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

Changes in nuclear morphology during apoptosis correlate with vimentin cleavage by different caspases located either upstream or downstream of Bcl-2 action

Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2.

The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1.

Identification of Non-HLA antigens targeted by alloreactive antibodies in patients undergoing chronic hemodialysis.

Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease.

Complement as a mediator of vascular inflammation and activation in allografts.

Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection.

P304

1459-1462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HUMIMM.2013.06.006

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239946925

http://www.w3.org/2001/XMLSchema#string

P698

23777935

http://www.w3.org/2001/XMLSchema#string

P921

cytoskeletal proteins

macromolecular substances

P932

3820003

http://www.w3.org/2001/XMLSchema#string